Boston Scientific Corporation announced CE mark and introduction in Europe of the Intracept™ Intraosseous Nerve Ablation System. The Intracept system is the only treatment specifically designed to target the basivertebral nerve for the relief of chronic vertebrogenic pain, offering a new treatment option for patients affected by this type of low back pain. The minimally invasive procedure uses targeted radiofrequency energy to stop the basivertebral nerve from carrying pain signals to the brain, with 75 percent of patients experiencing long-lasting improvements in pain and back function after a single Intracept procedure.1
The first commercial Intracept procedure was performed by a team at Stoke Mandeville Hospital, Buckinghamshire Healthcare NHS Trust, in the United Kingdom led by Dr. David McKean, consultant musculoskeletal radiologist.
Read the full press release to learn more.
1. Khalil J, et al. Intraosseous basivertebral nerve ablation: 5-year outcomes from three long-term follow-upstudies. Interventional Pain Medicine, Volume 3, Issue 4, 2024,100529, ISSN 2772-5944, https://doi.org/10.1016/j.inpm.2024.100529.